← Leaderboards
Laura Kristin Newby
Duke University
$29,253,723
Attributed
$47,281,452
Total exposure
9
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $36.3M · FY2016–25$50M$37.5M$25M$12.5M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$167,607,685 · 10
By mechanism
U2C$161,003,719 · 6
U19$3,989,051 · 2
U24$2,119,283 · 1
K23$495,632 · 1
Top collaborators
- Phillip Brian Smith17 shared
- Daniel K Benjamin10 shared
- Laurie H Sanders2 shared
- Lisa M Wruck2 shared
Most similar at Duke University
Same institution · by research overlap
- Phillip Brian Smith$108,296,899
- Victoria L. Seewaldt$17,302,500
- Burton L Scott$954,495
- Jeffrey None Crawford$10,066,024
- Daniel K Benjamin$109,874,279
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsResearch PersonnelClinical ResearchOperationChild HealthProtocols DocumentationCommunitiesResourcesDesignCommunicationLeadershipProceduresResearch InstituteFundingScienceResearch DesignPoliciesChildhoodUnited States National Institutes Of HealthInfrastructureCollaborationsClinical TrialsInternationalBiobank
Grant awards (34)
The Gut Brain Parkinson's Disease Consortium (GBPDC): Coordinating and Data Management Center (CDMC)$1,475,399
U24 · FY2025 · DK
PREVENTABLE Biorepository and Laboratory$113,466
U19 · FY2025 · AG · contact PI
The Gut Brain Parkinson's Disease Consortium (GBPDC): Coordinating and Data Management Center (CDMC)$643,884
U24 · FY2024 · DK
PREVENTABLE Biorepository and Laboratory$228,889
U19 · FY2024 · AG · contact PI
ECHO Administrative Supplement - Neonatal Opioid Trials$999,813
U2C · FY2023 · OD
PREVENTABLE Biorepository and Laboratory$396,363
U19 · FY2023 · AG · contact PI
ECHO Coordinating Center$17,857,556
U2C · FY2022 · OD
ECHO Steering Committee Support and Communications Component$3,918,057
U2C · FY2022 · OD · contact PI
ECHO Administrative Supplement - Neonatal Opioid Trials$1,999,671
U2C · FY2022 · OD
ECHO Administrative Supplement - Coordinating Center$1,631,709
U2C · FY2022 · OD
PREVENTABLE Biorepository and Laboratory$866,197
U19 · FY2022 · AG · contact PI
ACT-NOW Data Sustainability - ECHO Administrative Supplement$99,877
U2C · FY2022 · OD
ECHO Coordinating Center$17,502,857
U2C · FY2021 · OD
ECHO Steering Committee Support and Communications Component$3,829,634
U2C · FY2021 · OD · contact PI
ECHO Administrative Supplement - Neonatal Opioid Trials$1,500,000
U2C · FY2021 · OD
ECHO Coordinating Center$14,970,707
U2C · FY2020 · OD
ECHO Administrative Supplement - Neonatal Opioid Trials$7,000,000
U2C · FY2020 · OD
ECHO Steering Committee Support and Communications Component$3,284,195
U2C · FY2020 · OD · contact PI
PREVENTABLE Biorepository and Laboratory$1,460,476
U19 · FY2020 · AG · contact PI
ECHO Coordinating Center$7,853,592
U2C · FY2019 · OD
Project-002$6,750,000
U2C · FY2019 · OD
ECHO Steering Committee Support and Communications Component$1,908,026
U2C · FY2019 · OD · contact PI
PREVENTABLE Biorepository and Laboratory$923,660
U19 · FY2019 · AG · contact PI
ECHO Coordinating Center$15,926,881
U2C · FY2018 · OD
ECHO Steering Committee Support and Communications Component$2,815,263
U2C · FY2018 · OD · contact PI
ECHO Coordinating Center$18,172,311
U2C · FY2017 · OD
Project-005$12,872,250
U2C · FY2017 · OD
Project-003$4,544,270
U2C · FY2017 · OD
Project-002$755,791
U2C · FY2017 · OD
ECHO Coordinating Center$14,811,259
U2C · FY2016 · OD
MECHANISMS OF HORMONE THERAPY IN POSTMENOPAUSAL WOMEN$129,663
K23 · FY2003 · HL
MECHANISMS OF HORMONE THERAPY IN POSTMENOPAUSAL WOMEN$128,694
K23 · FY2002 · HL
MECHANISMS OF HORMONE THERAPY IN POSTMENOPAUSAL WOMEN$127,787
K23 · FY2001 · HL
MECHANISMS OF HORMONE THERAPY IN POSTMENOPAUSAL WOMEN$109,488
K23 · FY2000 · HL